eNauka - pregled

Pregled prema Autor Misgav, M

Prikaz rezultata 1 do 3 od 3
GodinaNaslovAutor(i)Tip rezultataMp-kat.
2013Association between predicted FVIII levels and risk of bleeding episodes in clinical trials with turoctocog alfa, a new rFVIII product from Novo NordiskOzelo, MC; Veljkovic, Dobrila K; Klamroth, R; Misgav, M; Nielsen, R; Groth, AKonferencijski rad
Mp kategorija će biti prikazana naknadno.
2012Safety and efficacy of turoctocog alfa during prevention and treatment of bleeds in adult and adolescent patients with severe haemophilia ALentz, SR; Misgav, M; Ozelo, MC; Zupancic-Salek, Silva; Veljkovic, Dobrila K; Recht, M; Cerqueira, MH; Tiede, Andreas; Brand, B; Mancuso, ME;
Martinowitz, U;
Konferencijski rad
Mp kategorija će biti prikazana naknadno.
2012Surgery with Turoctocog Alfa: Efficacy and Safety in Bleeding Prevention During Surgical Procedures - Results From the guardian (TM) TrialsSantagostino, Elena; Lentz, SR; Misgav, M; Brand, B; Chowdary, Pratima; Savic, Aleksandar D  ; Kilinc, Yurdanur; Tuddenham, Edward GD; Lindblom, AKonferencijski rad
Mp kategorija će biti prikazana naknadno.